EFFICACIA E TOLLERABILITA DELL'ANIRACETAM IN PAZIENTI ANZIANI AFFETTI DA DETERIORAMENTO MENTALE PRIMITIVO E SECONDARIO

Translated title of the contribution: Efficacy and tolerability of aniracetam in primary and secondary mental deterioration in the elderly

V. Canonico, L. Forgione, C. Paoletti, A. Casini, C. V. Colonna, M. Bertini, R. Acito, F. Rengo

Research output: Contribution to journalArticle

Abstract

The study was carried out on 60 patients (mean age 69.9 ± 10.3 years) suffering from slight-moderate brain pathology primary or secondary to vascular forms. Patients were treated with 1500 mg/day per os of Aniracetam or placebo. Drug efficiency evaluation was performed utilizing the following psychometrics tests: Blessed Scale, figures repetition test, Benton test, Corsi test, Rey test, Pieron test, phrases construction test, verbal fluency test. They were carried out during the first and second control. In placebo treated group no change statistically considerable happened in any test. Aniracetam has proved to be a useful drug in slight-moderate brain decay treatment of the elderly.

Original languageItalian
Pages (from-to)92-96
Number of pages5
JournalRivista di Neurologia
Volume61
Issue number3
Publication statusPublished - 1991

    Fingerprint

ASJC Scopus subject areas

  • Clinical Neurology

Cite this

Canonico, V., Forgione, L., Paoletti, C., Casini, A., Colonna, C. V., Bertini, M., Acito, R., & Rengo, F. (1991). EFFICACIA E TOLLERABILITA DELL'ANIRACETAM IN PAZIENTI ANZIANI AFFETTI DA DETERIORAMENTO MENTALE PRIMITIVO E SECONDARIO. Rivista di Neurologia, 61(3), 92-96.